Skip to content

Pre-clinical Application Study of Novel Stem Cell to Treat Incurable Eye Disease

Pre-clinical Application Study of Novel Stem Cell to Treat Incurable Eye Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-16009353
Enrollment
Unknown
Registered
2016-10-10
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis pigmentosa,corneal ulcer

Interventions

RP control group:No treatment
RP treatment group:autologous mesenchymal stem cells treatment
CU control group:eye drops
CU treatment group:autologous limbus stomal stem cell tratment

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (RP patients)Inclusion Criteria: 1. Male ageed 45-60 years, male; 2. Retinitis pigmentosa patients with similar vision of both eyes; 3. History of night blindness, disease history more than 5 years; 4. Retinal fundus: bone cells or irregular pigmentation, shrink color of optic disc, macular pardon area (no pigmentation); 5. Vision field< 20 degree, and electroretinogram (ERG) showed a significant decrease of volatility of b wave; (Corneal ulcer patients) Inclusion Criteria: 1. Male and female aged 18-70 years; 2. Corneal ulcer of both eyes with similar vision; 3. Corneal appearance: corneal ulcer under the slit lamp, stromal layer was involved; corneal endothelial was in good condition.

Exclusion criteria

Exclusion criteria: (RP patients)Exclusion Criteria: 1. monocular or secondary RP, nystagmus, high myopia, macular edema in OCT, a serious eye disease (cataract, cornea degeneration), previous eye surgery and eye conditions that influenced the results observed can't follow up; 2. Systemic disease (asthma, heart failure, myocardial infarction, liver failure, kidney failure and other major diseases); serious adverse reaction and systemic diseases during the follow-up period. (Corneal ulcer patients) Exclusion Criteria: 1. Conjunctivitis, keratitis in acute period, a serious eye disease (cataract, cornea degeneration), previous eye surgery and eye conditions that influenced the results observed; 2. can't follow up; 3. Systemic disease (asthma, heart failure, myocardial infarction, liver failure, kidney failure and other major diseases); serious adverse reaction and systemic diseases during the follow-up period.

Design outcomes

Primary

MeasureTime frame
Visual Acuity;Corneal ulcer diameter;anterior chamber;

Countries

China

Contacts

Public ContactFang Wang

Shanghai Tenth People's Hospital

18917683335@163.com+86 18917683335

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026